Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)

Clinical trial NCT06489028 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06489028
Sponsor: RHEACELL GmbH & Co. KG
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Venous Leg Ulcer

Start date: 2024-12-26
Primary completion: 2027-04-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.